1 MEDICAL/SURGICAL LASER UPDATE - American Society for ...

that perform tasks such as resurfacing the skin and removing hair and tattoos have been
approved and are ready to move into the marketplace.
Relyea said he feels positive about the company's stock. But Doss said he will reserve
judgment until the new chief is named. "I think it's way too early to know what's going
to happen to this company until we find out who the new chief executive's going to be,"
he said. "When you deal with little companies, you bet on the jockey and not the horse."
6/28 ESC Medical Systems Ltd. announced the voting results from the Combined Annual and
Extraordinary General Meeting of shareholders held on June 23, 1999 in New York City.
According to the final certified report of the Independent Inspectors of Election, the
seven director nominees proposed by Messrs. Arie Genger and Barnard Gottstein were
elected. Those nominees were Aharon Dovrat, Philip Friedman, Thomas Hardy, Darrell
Rigel, MD, S.A. Spencer, Mark Tabak and Professor Zehev Tadmor. Furthermore, in
accordance with the agreement between the company and Messrs. Genger and Gottstein,
at the first meeting of the newly elected Board held today, the Board was reconstituted
to add back as members Shimon Eckhouse and the four outside incumbent directors,
Messrs. Halley Faust, Marshall Butler, Kenneth Rind and Dan Suesskind.
Each of the seven Genger Gottstein nominees elected received votes from ESC
shareholders representing 11,860,681 shares, while the incumbent slate of nominees
received 8,566,545 shares. In addition, shareholders did not approve the motion to
adjourn the meeting and the proposal on the original meeting agenda concerning
indemnification of directors with respect to certain litigation. The proposal for the
re-appointment of the auditor was approved. There were 20,889,941 shares voted at the
meeting, representing approximately 76% of the shares outstanding.
6/28 Cell Robotics International said that Chronimed, its exclusive worldwide distributor of
CRII's Professional and Personal Lasette products, showed the Personal Lasette prototype
at the American Diabetes Association (ADA) meeting held in San Diego. According to
CRII president Dr. Ronald K. Lohrding, "I was delighted with the number of people who
were eager to get Personal Lasettes for the children they were treating. The awareness
of and enthusiasm for the Personal Lasette exceeded my expectations."
The Lasette is the only home-use alternative to the stainless steel lancet that is cleared by
the FDA for collecting blood samples to monitor glucose levels and is the first medical
laser device ever cleared by the FDA for use in the home. Two weeks ago Cell Robotics
delivered 27 prototypes of the Personal Lasette to Chronimed, which in turn, distributed
the prototypes to diabetic individuals for use in their homes in order to collect customer
input into the final design. The Personal Lasette will be featured by Chronimed at the
American Association of Diabetes Educators (AADE) annual conference, Aug. 18-21,
1999, in Orlando, Fla. If no supply problems develop, the Personal Lasette will be in
production in September with enough inventories to start aggressive sales in October.
134